Navigation Links
Boston Scientific Welcomes Results of Brain Aneurysm Clinical Trial
Date:5/26/2009

eeding from a coiled aneurysm in the first five years, fewer coiled patients died at five years, and there have been no observed hemorrhages from a coiled aneurysm in these patients after five years."

"The extraordinary work by Drs. Molyneux and Kerr and the ISAT investigators represents a milestone in the evolution of treatment for cerebral aneurysms," said Mark Paul, President, Boston Scientific Neurovascular. "The data from ISAT over the last six years have informed the worldwide neurovascular community and helped physicians better determine the best treatment options for patients suffering from a ruptured aneurysm."

The primary objective of ISAT was to determine whether endovascular treatment reduced the rates of patient death or dependency at one year compared with surgical treatment. The trial, supported by the U.K.'s Medical Research Council (MRC), began as a pilot study in 1994 and enrolled 2,143 patients at 43 neurosurgical centers who were randomly assigned to coiling or clipping. Patients were primarily treated with the early generation of Boston Scientific's GDC(R) Coils, some as far back as 14 years when technology, angiographic imaging equipment and physician experience differed significantly from today. One-year results reported in 2002 demonstrated a 24 percent relative risk reduction in death or dependency in patients treated with endovascular coiling compared to surgical clipping, which is consistent with five-year results.

"ISAT has required the dedication of doctors, nurses, trial staff, patients and their relatives over many years, and we are extremely grateful to them all," said Dr. Molyneux. "The positive trial results should reassure patients and physicians that treatment with endovascular coiling is safe in the short term while also providing a long-term benefit of lower death risk compared to surgical intervention. The latest data continue to support the general shift toward coili
'/>"/>

SOURCE Boston Scientific Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Boston Scientific Begins Clinical Trial for Next-Generation Nitinol Stent to Treat Iliac Artery Disease
2. Boston Scientific Launches Third-Generation Platinum Chromium Drug-Eluting Stent
3. Boston Scientific Data Show Real-World Survival Rates for Implantable Cardiac Device Patients Exceed Rates From Clinical Trials
4. Journal of American College of Cardiology Article Reports Fewer Repeat Procedures With Boston Scientifics TAXUS(R) Liberte(R) Stent
5. Boston Scientific Welcomes Publication of HORIZONS AMI Trial Results in New England Journal of Medicine
6. Clinical Data Reinforce Safety and Efficacy of Boston Scientifics Two Drug- Eluting Stent Platforms
7. New England Journal of Medicine Publishes Results from Boston Scientifics Landmark SYNTAX(TM) Trial
8. Boston Scientific Submits Final Modules to FDA for Approval of Second-Generation Small Vessel and Long Lesion Stents
9. Boston Scientific Begins Clinical Trial Enrollment for New Everolimus-Eluting Stent
10. Taxus Atlas Studies Reinforce Safety and Efficacy of Boston Scientifics Next-Generation Taxus Liberte Stent
11. Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)...  Over the next five years, the marijuana industry in ... predicting that 14 more states will legalize recreational marijuana and ... for legal cannabis grew 74 percent in 2014 to $2.7 ... market could grow more than fourfold to $11 billion in ... on marijuana. Cannabiz Mobile Inc. (OTCBB: LGBI) is ...
(Date:4/17/2015)... Today, the Pharmaceutical Research and Manufacturers ... biopharmaceutical companies as "We Work For Health Champions" ... community service. Established in 2009, the ... by the biopharmaceutical industry to honor employees who ... have also shown an outstanding commitment to their ...
(Date:4/17/2015)...   IBA Molecular, a global leader in ... it has signed a definitive agreement to sell its ... to Illinois Health and Science (IHS). Under IHS ownership, IBAM ... headquartered in Dulles, Virginia , and ... product and footprint synergies. IBA Molecular is jointly owned ...
Breaking Medicine Technology:Cannabiz Mobile Analyst Brief: Next Big Thing by Torus IR Issued by BrokerBank Securities, Inc. 2PhRMA Applauds 2015 We Work For Health Champion Award Winners 2PhRMA Applauds 2015 We Work For Health Champion Award Winners 3Health Care System to Acquire IBA Molecular North America 2Health Care System to Acquire IBA Molecular North America 3
... Provider Network presented checks totaling $80,000 to the two ... the Strata Conference in Santa Clara, California. The global ... Once again, the team of "Market Makers" ... Players include David Vogel, CEO and Chief Scientist of ...
... Food and Drug Administration (FDA) has cleared InTone™, a ... "InTone is a true medical breakthrough, and welcome ... issues," said Herschel "Buzz" Peddicord, president & CEO of ... we believe we can effectively treat this condition in ...
Cached Medicine Technology:Heritage Provider Network Awards $80,000 to the Progress Prize Winners in the $3Million Heritage Health Prize Contest at the Strata Conference in Santa Clara, California 2Heritage Provider Network Awards $80,000 to the Progress Prize Winners in the $3Million Heritage Health Prize Contest at the Strata Conference in Santa Clara, California 3Medical Breakthrough for Incontinence From InControl Medical, LLC Cleared by FDA 2
(Date:4/17/2015)... (PRWEB) April 17, 2015 In Defense ... the following statement: “On Wednesday April 15th, the European ... adopted a resolution recognizing the Armenian Genocide, “paying tribute, ... of the one-and-a-half million innocent Armenian victims who perished ... (IDC) extols the EU for this timely and needed ...
(Date:4/17/2015)... Rapids, MI (PRWEB) April 17, 2015 Enthusiasts ... CRUSH Grand Rapids, Saturday, April 25, 2015. The event will ... Reserve Wine & Food (201 Monroe Ave NW, Grand Rapids, ... from around the West Michigan area. Patrons are encouraged to ... of elegance and fun. , This year’s event will feature ...
(Date:4/17/2015)... 2015 Most dental patients are not ... are made overseas by foreign dental laboratories, according to ... unregulated in more than 40 states by their respective ... of Dental Laboratories has created the “What’s ... patients about the consequences that could be associated with ...
(Date:4/17/2015)... Organic Valley, the nation’s largest cooperative ... International Year of Soils by “Cycling for Sustainability” through ... employees will travel 215 miles from Auburn, California, to ... about the impact of agriculture on water and soil ... Maine, Wisconsin, Oregon, and Washington state, the cyclists have ...
(Date:4/17/2015)... (PRWEB) April 17, 2015 Connie Casad, ... and functional medicine advocate with 30 years of practice ... be adding another level of service for her patients ... website of 10 recommended wellness books with a brief ... asked to explain her interest in providing this service, ...
Breaking Medicine News(10 mins):Health News:In Defense of Christians Condemns Armenian Genocide 2Health News:In Defense of Christians Condemns Armenian Genocide 3Health News:Children’s Leukemia Foundation of Michigan Presents 3rd Annual CRUSH Grand Rapids 2Health News:National Association Urges Transparency in Dental Industry 2Health News:Organic Valley Farmers and Employees "Cycling for Sustainability" Through 215 Miles of California Watershed April 19-25 2Health News:Organic Valley Farmers and Employees "Cycling for Sustainability" Through 215 Miles of California Watershed April 19-25 3Health News:Connie Casad, M.D. Provides Patients Recommended List of Wellness Books on Website 2
... 30% of all human cancer tumors, the Ras protein literally ... the Faculty of Life Sciences at Tel Aviv University. Prof. ... effective anti-Ras drug against pancreatic cancer, currently in clinical trials. ... European Journal of Pharmacology shows that the drug might be ...
... ... Conference Attendees: "We have no choice but to embrace our role as true reformers" ... Boston, MA ... (NACDS) President and CEO Steven C. Anderson, IOM, CAE, urged the 2009 Pharmacy & ...
... DALLAS, Aug. 10 The Fountain of Life Group was ... Fame unveiled its official 2009 Pro Football Hall of Fame Yearbook. ... ceremony as part of their support of the Hall,s flagship publication. ... of 1985 Hall of Famer Roger Staubach. , , ...
... Whether finding applies to today,s treatments remains unclear, experts ... at low doses, radiation therapy for low-grade brain tumors ... study reports. , Radiation is the most widely used ... most common type of brain cancer. , Researchers in ...
... , , , ... make known its response to recent criticism regarding President Obama,s nomination of ... Critics have suggested that because Dr. Benjamin is overweight, this sends the ... America,s health initiatives. , , A person,s body weight ...
... CONSHOHOCKEN, Pa., Aug. 10 The unique circumstances ... major role in decisions regarding security staffing, according to a ... ( All i edBarto n ... quality of service, professionalism and cost were cited as important ...
Cached Medicine News:Health News:Taking the needle's sting out of diabetes 2Health News:Anderson: Industry Advocacy, Engagement Key to Healthcare Reform 2Health News:Anderson: Industry Advocacy, Engagement Key to Healthcare Reform 3Health News:Anderson: Industry Advocacy, Engagement Key to Healthcare Reform 4Health News:Fountain of Life Group Debuts VaNu at the Pro Football Hall of Fame Enshrinement Weekend 2Health News:Radiation for Brain Tumors May Affect Cognition 2Health News:The Obesity Society Position on Recent Criticism of Surgeon General Nominee Regina Benjamin 2Health News:New Survey Identifies Specialized Training and Respect for Culture as Key Factors in Healthcare Security Personnel Selection 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: